The
performance of supramolecular nanocarriers as drug delivery
systems depends on their stability in the complex and dynamic biological
media. After administration, nanocarriers are challenged by physiological
barriers such as shear stress and proteins present in blood, endothelial
wall, extracellular matrix, and eventually cancer cell membrane. While
early disassembly will result in a premature drug release, extreme
stability of the nanocarriers can lead to poor drug release and low
efficiency. Therefore, comprehensive understanding of the stability
and assembly state of supramolecular carriers in each stage of delivery
is the key factor for the rational design of these systems. One of
the main challenges is that current 2D in vitro models
do not provide exhaustive information, as they fail to recapitulate
the 3D tumor microenvironment. This deficiency in the 2D model complexity
is the main reason for the differences observed in vivo when testing the performance of supramolecular nanocarriers. Herein,
we present a real-time monitoring study of self-assembled micelles
stability and extravasation, combining spectral confocal microscopy
and a microfluidic cancer-on-a-chip. The combination of advanced imaging
and a reliable 3D model allows tracking of micelle disassembly by
following the spectral properties of the amphiphiles in space and
time during the crucial steps of drug delivery. The spectrally active
micelles were introduced under flow and their position and conformation
continuously followed by spectral imaging during the crossing of barriers,
revealing the interplay between carrier structure, micellar stability,
and extravasation. Integrating the ability of the micelles to change
their fluorescent properties when disassembled, spectral confocal
imaging and 3D microfluidic tumor blood vessel-on-a-chip resulted
in the establishment of a robust testing platform suitable for real-time
imaging and evaluation of supramolecular drug delivery carrier’s
stability.